Skip to main content

Table 5 AEs and drug-related AEs

From: Effectiveness of combination therapy with nifedipine GITS: a prospective, 12-week observational study (AdADOSE)

  AEs Drug-related AEs
Total, patients (%); n = 4477 142 (3.2) 114 (2.6)
Peripheral edema, n (%) 54 (1.2) 48 (1.1)
Headache, n (%) 28 (0.6) 26 (0.6)
Edema, n (%) 15 (0.3) 9 (0.2)
Palpitations, n (%) 11 (0.3) 9 (0.2)
Flushing, n (%) 10 (0.2) 10 (0.2)
Constipation, n (%) 5 (0.1) 5 (0.1)
Dizziness, n (%) 5 (0.1) 5 (0.1)
  1. Incidence of AEs and drug-related AEs (≥0.1 % incidence) in patients during treatment with nifedipine GITS in combination with other antihypertensive agents
  2. AEs adverse events, GITS gastrointestinal therapeutic system